Latest filing published 25 Jun 2026 for MapLight Therapeutics, Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Timothy John Garnett: trading record in brief
Timothy John Garnett appears in our data through filings on MapLight Therapeutics, Inc. shares, published by SEC (Form 4). The record holds 3 filings, for trades running from 27 October 2025 to 23 June 2026.
On the market, this insider has only ever bought: 1 purchase, €212k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants. Since January 2026: 1 purchase and no sales on the market.
On 25 June 2026 came the latest disclosure, a share grant in MapLight Therapeutics, Inc. The last insider purchase was made public on 12 February 2026, 271 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Timothy John Garnett
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,932 sharesVoting Common StockSEC:0001998937-26-000004:0
- 6,294 shares0Voting Common StockSEC:0001998937-25-000006:0
2 of 2 declarations